Question: Rhode Island Subscriber Answer: You should report a code from the 733.0x series (Osteoporosis), 733.90 (Disorder of bone and cartilage, unspecified) or 255.0 (Cushing's syndrome). But you must also have a valid ICD-9 code from the list your local contractor maintains to indicate the reason a physician ordered the screening: postmenopausal female, vertebral fracture, hyperparathyroidism, or steroid therapy. Remember: You should choose the appropriate code based on the radiologist's documentation. The above rule on double diagnoses applies if you report any of the following codes to Medicare for monitoring patients on osteoporosis drugs: • 76977 -- Ultrasound bone density measurement and interpretation, peripheral site(s), any method • 77079 -- Computed tomography, bone mineral density study, 1 or more sites; appendicular skeleton (peripheral) (e.g., radius, wrist, heel) • 77081 -- Dual-energy x-ray absorptiometry (DXA), bone density study, 1 or more sites; appendicular skeleton (peripheral) (e.g., radius, wrist, heel) • 77083 -- Radiographic absorptiometry (e.g., photodensitometry, radiogrammetry), 1 or more sites • G0130 -- Single energy x-ray absorptiometry (SEXA) bone density study, one or more sites; appendicular skeleton (peripheral) (e.g., radius, wrist, heel). Tip: Don't miss: If you report 77080 (Dual-energy x-ray absorptiometry [DXA], bone density study, 1 or more sites; axial skeleton [e.g., hips, pelvis, spine]), Medicare will cover the test without the additional code from your local contractor. Codes 733.0x, 733.90 and 255.0 each earn coverage for this test.